Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 4044-4046, September 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, B.
Right arrow Articles by Tohyama, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, B.
Right arrow Articles by Tohyama, C.

Metallothionein Deficiency Promotes Mouse Skin Carcinogenesis Induced by 7,12-Dimethylbenz[a]anthracene1

Baoxu Zhang, Masahiko Satoh, Noriko Nishimura, Junko S. Suzuki, Hideko Sone, Yasunobu Aoki and Chiharu Tohyama2

Environmental Health Sciences Division, National Institute for Environmental Studies, Tsukuba, Ibaraki 305-0053, Japan [B. Z., M. S., N. N., J. S. S., H. S., Y. A., C. T.], and Department of Toxicology, Institute of Environmental Medicine, School of Public Health, Beijing Medical University, Beijing 100083, China [B. Z.]

To investigate a possible involvement of metallothionein (MT) in chemical carcinogenesis, MT-I and MT-II gene-deficient [MT (-/-)] transgenic mice and wild-type [MT (+/+)] control mice were topically applied at a single dose of 100, 250, 500, or 1000 µg of 7,12-dimethylbenz[a]anthracene (DMBA) on the dorsal skin and thereafter compared. After 14 weeks of DMBA treatment, the skin tumor occurred in MT (-/-) mice only and in a dose-dependent manner, whereas no change was observed in MT (+/+) mouse skin given the same DMBA treatment. The tumor cells showed proliferative activity, as shown by proliferative cell nuclear antigen staining. These results demonstrate that MT acts as an endogenous defensive factor against DMBA-induced skin tumorigenesis.

1 This work was supported in part by Eco-Frontier Fellowship of Environmental Agency (to B. Z.).

2 To whom requests for reprints should be addressed.

Received 6/18/98. Accepted 7/28/98.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
J. S. Suzuki, N. Nishimura, B. Zhang, Y. Nakatsuru, S. Kobayashi, M. Satoh, and C. Tohyama
Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice
Carcinogenesis, June 1, 2003; 24(6): 1123 - 1132.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. J. Long II, R. L. Waikel, X.-J. Wang, D. R. Roop, and A. K. Jaiswal
NAD(P)H : quinone Oxidoreductase 1 Deficiency and Increased Susceptibility to 7,12-Dimethylbenz[a]-anthracene-Induced Carcinogenesis in Mouse Skin
J Natl Cancer Inst, August 1, 2001; 93(15): 1166 - 1170.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Takaba, K. Saeki, K. Suzuki, H. Wanibuchi, and S. Fukushima
Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate
Carcinogenesis, April 1, 2000; 21(4): 691 - 700.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Chen, Y. W. Ding, G.-y. Yang, F. Bondoc, M.-J. Lee, and C. S. Yang
Oxidative damage in an esophageal adenocarcinoma model with rats
Carcinogenesis, February 1, 2000; 21(2): 257 - 263.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Kondo, S. Himeno, W. Endo, M. Mita, Y. Suzuki, K. Nemoto, M. Akimoto, J. S. Lazo, and N. Imura
Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice
Carcinogenesis, August 1, 1999; 20(8): 1625 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. E. Burczynski, H.-K. Lin, and T. M. Penning
Isoform-specific Induction of a Human Aldo-Keto Reductase by Polycyclic Aromatic Hydrocarbons (PAHs), Electrophiles, and Oxidative Stress: Implications for the Alternative Pathway of PAH Activation Catalyzed by Human Dihydrodiol Dehydrogenase
Cancer Res., February 1, 1999; 59(3): 607 - 614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.